S&P 500 rises as health care, tech gain to overshadow Fed independence concerns
CARLSBAD, CA— Alphatec Holdings , Inc. (NASDAQ:ATEC) Chief Financial Officer John Todd Koning has sold a significant portion of his holdings in the company. According to a recent SEC filing, Koning disposed of 165,121 shares of common stock on March 10, 2025, generating approximately $1.6 million in proceeds. The sale comes as ATEC shares have declined 13% over the past week, though the stock maintains an impressive 82% gain over the last six months. InvestingPro analysts have set price targets ranging from $11 to $22.50, suggesting potential upside.
The shares were sold at an average price of $9.72, with individual transaction prices ranging from $9.43 to $10.35. This transaction was conducted under a Rule 10b5-1 trading plan, which Koning adopted in June 2023 and amended in November 2023. The plan was designed to cover tax withholding obligations related to the vesting of restricted stock units. With a market capitalization of $1.38 billion and a healthy current ratio of 2.73, the company maintains strong liquidity despite not being profitable in the last twelve months.
After the sale, Koning retains ownership of 483,107 shares in the company. Alphatec Holdings, based in Carlsbad, California, specializes in surgical and medical instruments. Get deeper insights into ATEC’s insider trading patterns and comprehensive financial analysis with InvestingPro’s detailed research reports.
In other recent news, Alphatec Holdings reported its fourth-quarter 2024 earnings, revealing a revenue of $177 million, surpassing the projected $170.35 million. However, the company’s earnings per share (EPS) of -$0.23 fell short of the expected -$0.05. Despite the EPS miss, Alphatec achieved a 28% year-over-year revenue growth and its first quarter of positive cash flow since its transformation. The company has issued guidance for 2025, projecting a 20% revenue growth to $732 million. In financial maneuvers, Alphatec has issued $405 million in convertible senior notes due 2030, while repurchasing $253 million of its notes due 2026. TD Cowen reaffirmed its Buy rating for Alphatec, maintaining a price target of $22.50, citing the company’s solid financial performance and market share expansion. Additionally, Alphatec plans to use proceeds from its convertible notes offering to fund capped call transactions and repurchase existing notes. These developments highlight Alphatec’s strategic financial and operational initiatives aimed at sustaining growth and market positioning.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.